How can mRNA become the UK’s next strategic growth engine?
From cancer and respiratory illnesses to rare diseases, mRNA offers promise. Can Britain turn it into an economic superpower?
Sponsored
Latest in
Sponsored
Partner content
The need for deep and lasting life science partnerships
The government is on a mission to make sure the next great health breakthroughs happen, and are commercialised, in the…
By
Partner content
The value of vaccinations
Beyond being a public health intervention, vaccinations strengthen communities and help grow the economy.
By
Partner content
Infographic: Moderna’s strategic partnership with the UK government
A look at the numbers behind a ten-year partnership aiming to boost the UK’s health resilience, its life sciences sector,…
Partner content
An investment in jobs, skills, and industrial capacity
This model of collaboration between government and business will anchor Britain as a global hub of innovation.
By
Partner content
An investment in the future
Moderna’s ten-year partnership with the UK government hopes to position the country at the cutting edge of mRNA technology.
Partner content
A flagship for vaccine innovation
The MITC aspires to boost UK pandemic readiness, global trials, and the next generation of scientific talent.
Partner content
A special supplement, sponsored by Takeda and Crohn’s & Colitis UK, looking at how the UK can better serve those…
By